These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 21075045
1. hMLH1 promoter methylation is an early event in oral cancer. González-Ramírez I, Ramírez-Amador V, Irigoyen-Camacho ME, Sánchez-Pérez Y, Anaya-Saavedra G, Granados-García M, García-Vázquez F, García-Cuellar CM. Oral Oncol; 2011 Jan; 47(1):22-6. PubMed ID: 21075045 [Abstract] [Full Text] [Related]
2. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D. Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881 [Abstract] [Full Text] [Related]
3. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Viswanathan M, Tsuchida N, Shanmugam G. Int J Cancer; 2003 May 20; 105(1):41-6. PubMed ID: 12672028 [Abstract] [Full Text] [Related]
4. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM. Am J Otolaryngol; 2011 May 20; 32(6):528-36. PubMed ID: 21353335 [Abstract] [Full Text] [Related]
5. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma. Tzao C, Hsu HS, Sun GH, Lai HL, Wang YC, Tung HJ, Yu CP, Cheng YL, Lee SC. J Thorac Cardiovasc Surg; 2005 Nov 20; 130(5):1371. PubMed ID: 16256791 [Abstract] [Full Text] [Related]
6. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer. Zhang H, Zhang S, Cui J, Zhang A, Shen L, Yu H. Aust N Z J Obstet Gynaecol; 2008 Oct 20; 48(5):505-9. PubMed ID: 19032668 [Abstract] [Full Text] [Related]
7. The mismatch repair gene hPMS1 (human postmeiotic segregation1) is down regulated in oral squamous cell carcinoma. Wang Y, Zhou X, Song Y, Ji X, Zhang A, Zhang G, Gao Z. Gene; 2013 Jul 15; 524(1):28-34. PubMed ID: 23608172 [Abstract] [Full Text] [Related]
8. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY. Otolaryngol Head Neck Surg; 2009 Oct 15; 141(4):484-90. PubMed ID: 19786217 [Abstract] [Full Text] [Related]
9. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas. Strazzullo M, Cossu A, Baldinu P, Colombino M, Satta MP, Tanda F, De Bonis ML, Cerase A, D'Urso M, D'Esposito M, Palmieri G. Cancer; 2003 Oct 01; 98(7):1540-6. PubMed ID: 14508843 [Abstract] [Full Text] [Related]
10. Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Liu K, Huang H, Mukunyadzi P, Suen JY, Hanna E, Fan CY. Otolaryngol Head Neck Surg; 2002 May 01; 126(5):548-53. PubMed ID: 12075230 [Abstract] [Full Text] [Related]
11. Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Jha R, Gaur P, Sharma SC, Das SN. Gene; 2013 Sep 10; 526(2):223-7. PubMed ID: 23727610 [Abstract] [Full Text] [Related]
12. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy. Fernandes AM, Ramos-Jorge ML, Cardoso SV, Loyola AM, Mesquita RA, Aguiar MC. J Oral Pathol Med; 2008 Oct 10; 37(9):543-8. PubMed ID: 18331286 [Abstract] [Full Text] [Related]
13. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis]. Wang F, Xie XJ, Piao YS, Liu B, Wang LD. Zhonghua Bing Li Xue Za Zhi; 2011 Aug 10; 40(8):537-41. PubMed ID: 22169643 [Abstract] [Full Text] [Related]
14. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia. Lenz G, Hutter G, Hiddemann W, Dreyling M. Ann Hematol; 2004 Oct 10; 83(10):628-33. PubMed ID: 15309527 [Abstract] [Full Text] [Related]
15. Implication of Reprimo and hMLH1 gene methylation in early diagnosis of gastric carcinoma. Liu L, Yang X. Int J Clin Exp Pathol; 2015 Oct 10; 8(11):14977-82. PubMed ID: 26823831 [Abstract] [Full Text] [Related]
16. [Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability]. Li JH, Shi XZ, Liu M, Wang Y, Yu ZH, Xu GW, Lu S. Ai Zheng; 2005 Mar 10; 24(3):273-7. PubMed ID: 15757526 [Abstract] [Full Text] [Related]
17. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas. Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T. Oncol Rep; 2009 Nov 10; 22(5):1173-9. PubMed ID: 19787237 [Abstract] [Full Text] [Related]
18. [Status of methylation of promoter of mis-match repair gene hMLH1 in lung cancer]. Chen G, Liu T, He J. Zhonghua Zhong Liu Za Zhi; 2000 Nov 10; 22(6):493-5. PubMed ID: 11235573 [Abstract] [Full Text] [Related]
19. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. Wang YC, Lu YP, Tseng RC, Lin RK, Chang JW, Chen JT, Shih CM, Chen CY. J Clin Invest; 2003 Mar 10; 111(6):887-95. PubMed ID: 12639995 [Abstract] [Full Text] [Related]
20. Promoter hypermethylation of mismatch repair gene hMLH1 predicts the clinical response of malignant astrocytomas to nitrosourea. Fukushima T, Katayama Y, Watanabe T, Yoshino A, Ogino A, Ohta T, Komine C. Clin Cancer Res; 2005 Feb 15; 11(4):1539-44. PubMed ID: 15746058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]